Michael Boehler
About Michael Boehler
Michael Boehler, MD, is based in Vienna, Austria. Crunchbase lists him as Chairman of the Board of VALANX Biotech. His education includes the University of Freiburg, Innsbruck Medical University and Rotterdam School of Management, Erasmus University.
In August 2025, clock.bio announced his appointment as Chief Business Officer. The company develops therapies to reverse aging. The announcement cites more than 20 years in life sciences across commercial, general management and business development roles.
He was previously a Vice President Global Commercial and General Manager at BioNTech. The announcement says he built BioNTech's global commercial organization, set up its first integrated country organization in Europe and contributed to its IPO. Before that he held senior roles at Takeda, Kite Pharma and Amgen, mainly in oncology.
The clock.bio announcement says he worked as an advisor, angel investor and board member to early-stage biotech companies before joining. It does not name those companies. Crunchbase shows one personal investment, in Modern Relay. We found no public list of his other angel investments, and no public statement of check size or fund size.
In April 2026, Michael Boehler took part in Modern Relay's seed round of EUR 2.5M (about $3M). Point Nine, Emerge, Amino Collective and Common Magic also participated, along with angels Charlie Songhurst and Thomas Clozel.
Modern Relay was founded in 2025 by Ragnor Comerford and Aaron Go. It builds shared infrastructure for enterprise AI, including a governed "context graph" for knowledge shared between people and AI agents. With the round it released Omnigraph, an open-source graph database built for agents. EU-Startups describes him in this round as a former BioNTech executive.
His only public AI deal is an early-stage enterprise AI infrastructure company. His earlier angel and board work was in early-stage biotech. He is based in Europe. He has not publicly stated a check size, stage preference or thesis, so none is given here. Founders should treat him as an operator-angel with a life sciences background. His appeal is likely strongest for AI companies selling into pharma, biotech or other regulated enterprise settings. That is an inference, not something he has said.
- Modern Relay: shared infrastructure layer for enterprise AI agents and a context graph for organizational knowledge. He invested in its April 2026 seed round of EUR 2.5M ($3M).
Investing activity
Michael Boehler appears in 1 AI deal tracked by the Lounge deals desk. The rounds are mostly Seed, with a median round size of $3M. The most recent is Modern Relay (Seed, $2.9M (EUR 2.5M), Apr 2026).
Michael Boehler most often invests alongside Amino Collective, Charlie Songhurst, Thomas Clozel and Common Magic, and the companies they back on Lounge are mostly in AI.
Deals
Frequently asked questions about Michael Boehler
Who is Michael Boehler?
He is a Vienna-based physician and life sciences executive. He is a former BioNTech Vice President and was named Chief Business Officer of clock.bio in August 2025. He also invests as an angel.
Has Michael Boehler invested in AI startups?
Yes. He was an angel in Modern Relay's April 2026 seed round of EUR 2.5M ($3M). Modern Relay builds enterprise AI infrastructure for agents. It is the only AI investment we found for him.
What is Michael Boehler's angel check size?
It is not public. We found no statement from him or reporting on his check size, so we do not give a figure.
What stage does Michael Boehler invest in?
His one public AI investment is a seed round. His earlier angel work was with early-stage biotech companies. He has not published a formal stage focus.
Does Michael Boehler only back biotech?
His background and earlier angel work are in biotech, but the Modern Relay investment shows he has also backed enterprise AI software. Beyond that deal we found no stated sector focus.
How can founders contact Michael Boehler?
His LinkedIn profile is the only public channel we found. We found no personal website or X account, so a warm introduction through a shared connection is more likely to work than a cold message.
Is Michael Boehler an angel investor?
Yes. Michael Boehler invests personally as an angel.
What AI companies has Michael Boehler invested in?
Michael Boehler's AI investments include Modern Relay. The 1 round on Lounge are listed on this page with amounts, dates and co-investors.
What stage does Michael Boehler invest at?
In the rounds tracked on Lounge, Michael Boehler has invested at Seed, with a median round of $3M.
Who does Michael Boehler co-invest with?
Michael Boehler's most frequent co-investors on Lounge are Amino Collective (1 deal), Charlie Songhurst (1 deal), Thomas Clozel (1 deal), Common Magic (1 deal) and Point Nine (1 deal).